HuGE Literature Finder
|
||
Records 1-28
|
Association of HFE gene mutations with nonalcoholic fatty liver disease in the Iranian population.
Cellular and molecular biology (Noisy-le-Grand, France) 2016 Oct 62 (12): 123-128. Saremi L, Lotfipanah S, Mohammadi M, Hosseinzadeh H, Sayad A, Saltanatpour |
|
Correlation between HFE gene polymorphisms and increased risk of coronary artery disease among patients with type 2 diabetes in Iran.
Turkish journal of medical sciences 2016 46 (3): 590-6. Saremi Leila, Saremi Marzieh, Lotfipanah Shirin, ?mani Saber, Fu Junjiang, Zhang Tian |
|
Diabetes in first-degree family members: a predictor of type 2 diabetes in 159 nonscreening Alabama hemochromatosis probands with HFE C282Y homozygosity.
Diabetes care 2014 37 (1): 259-66. Barton James C, Barton J Clayborn, Acton Ronald |
|
Risk factors for development of dementia in a unique six-year cohort study. I. An exploratory, pilot study of involvement of the E4 allele of apolipoprotein E, mutations of the hemochromatosis-HFE gene, type 2 diabetes, and stroke.
Journal of Alzheimer's disease : JAD 2014 38 (4): 907-22. Percy Maire, Somerville Martin J, Hicks Mark, Garcia Angeles, Colelli Teresa, Wright Emily, Kitaygorodsky Julia, Jiang Amy, Ho Valerie, Parpia Alyssa, Wong Michael |
|
Hemochromatosis gene (HFE) polymorphisms and risk of type 2 diabetes mellitus: a meta-analysis.
American journal of epidemiology 2012 Sep 176 (6): 461-72. Rong Ying, Bao Wei, Rong Shuang, Fang Min, Wang Di, Yao Ping, Hu Frank B, Liu Liega |
|
Genetic determinants for body iron store and type 2 diabetes risk in US men and women.
PloS one 2012 7 (7): e40919. He Meian, Workalemahu Tsegaselassie, Manson JoAnn E, Hu Frank B, Qi |
|
Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the third National Health and Nutrition Examination Survey (NHANES III).
BMC medical genetics 2012 13 (1): 30. Grimsby Jonna L, Porneala Bianca C, Vassy Jason L, Yang Quanhe, Florez José C, Dupuis Josée, Liu Tiebin, Yesupriya Ajay, Chang Man-Huei, Ned Renee M, Dowling Nicole F, Khoury Muin J, Meigs James B, |
|
Bioinformatics-driven identification and examination of candidate genes for non-alcoholic fatty liver disease.
PloS one 2011 6 (1): e16542. Banasik Karina, Justesen Johanne M, Hornbak Malene, Krarup Nikolaj T, Gjesing Anette P, Sandholt Camilla H, Jensen Thomas S, Grarup Niels, Andersson Asa, Jørgensen Torben, Witte Daniel R, Sandbæk Annelli, Lauritzen Torsten, Thorens Bernard, Brunak Søren, Sørensen Thorkild I A, Pedersen Oluf, Hansen Torb |
|
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Diabetes care 2010 Oct 33 (10): 2250-3. Bailey Swneke D, Xie Changchun, Do Ron, Montpetit Alexandre, Diaz Rafael, Mohan Viswanathan, Keavney Bernard, Yusuf Salim, Gerstein Hertzel C, Engert James C, Anand Sonia, |
|
Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy.
BMC medical genetics 2010 11 (1): 158. Balasubbu Suganthalakshmi, Sundaresan Periasamy, Rajendran Anand, Ramasamy Kim, Govindarajan Gowthaman, Perumalsamy Namperumalsamy, Hejtmancik J Fieldi |
|
Frequency of the hemochromatosis gene (HFE) variants in a Jordanian Arab population and in diabetics from the same region.
Disease markers 2009 27 (1): 17-22. Alkhateeb Asem, Uzrail Amal, Bodoor Khald |
|
Lack of association of C282Y and H63D mutations in the hemochromatosis (HFE) gene with diabetes mellitus type 2 in a case-control study of women in Brazil.
Genetics and molecular research : GMR 2009 8 (4): 1285-91. Gomes K B, Carvalho M G, Coelho F F, Rodrigues I F, Soares A L, Guimarães D A, Fernandes A |
|
Prevalence, characteristics, and prognostic significance of HFE gene mutations in type 2 diabetes: the Fremantle Diabetes Study.
Diabetes care 2008 Sep 31 (9): 1795-801. Davis Timothy M E, Beilby John, Davis Wendy A, Olynyk John K, Jeffrey Gary P, Rossi Enrico, Boyder Conchita, Bruce David |
|
Hemochromatosis gene (HFE) mutations in patients with type 2 diabetes and their control group in an Iranian population.
Saudi medical journal 2008 Jun 29 (6): 808-12. Sharifi F, Esmaeilzadeh A, Zali M |
|
The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing.
European journal of gastroenterology & hepatology 2008 May 20 (5): 379-83. Watkins Stuart, Thorburn Douglas, Joshi Neeraj, Neilson Margaret, Joyce Theresa, Spooner Richard, Cooke Alexander, Mills Peter R, Morris A John, Stanley Adrian |
|
HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women.
Diabetes 2005 Dec 54 (12): 3567-72. Qi Lu, Meigs James, Manson JoAnn E, Ma Jing, Hunter David, Rifai Nader, Hu Frank |
|
The HFE gene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2.
Endocrine 2004 Jul 24 (2): 111-4. Oliva Rafael, Novials Anna, Sánchez Mayka, Villa Marga, Ingelmo Mercedes, Recasens Mónica, Ascaso Carlos, Bruguera Miquel, Gomis Ram |
|
Haemochromatosis-causing mutations C282Y and H63D are not risk factors for coronary artery disease in Caucasians with type 2 diabetes.
Folia biologica 2004 50 (2): 69-70. Zorc M, Hruskovicová H, Petrovic M Globocnik, Milci? M, Peterlin B, Petrovic |
|
Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case - control study.
Human molecular genetics 2003 Jun 12 (12): 1361-5. Halsall David J, McFarlane Ian, Luan Jian'an, Cox Timothy M, Wareham Nicholas |
|
A search for association between hereditary hemochromatosis HFE gene mutations and type 2 diabetes mellitus in a Polish population.
Medical science monitor : international medical journal of experimental and clinical research 2003 Feb 9 (2): BR91-5. Ma?ecki Maciej T, Klupa Tomasz, Walu? Ma?gorzata, Czoga?a Wojciech, Greenlaw Paul, Sieradzki Jac |
|
Health implications of iron overload: the role of diet and genotype.
Nutrition reviews 2003 Feb 61 (2): 45-62. Heath Anne-Louise M, Fairweather-Tait Susan |
|
A hemochromatosis-causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetes.
Journal of human genetics 2003 48 (12): 646-9. Peterlin Borut, Globocnik Petrovic Mojca, Makuc Jana, Hawlina Marko, Petrovic Dani |
|
The C282Y/wt heterozygous HFE genotype is associated with lower blood pressure and HDL-cholesterol in Type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 2002 Sep 19 (9): 796. Hermans M P, Van Lerberghe S, Buysschaert |
|
Relations among serum ferritin, C282Y and H63D mutations in the HFE gene and type 2 diabetes mellitus in the Czech population.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2002 Aug 110 (5): 223-9. Kanková K, Jansen E H J M, Márová I, Stejskalová A, Pácal L, Muzík J, Vácha |
|
Clinical expression and insulin sensitivity in type 2 diabetic patients with heterozygous mutations for haemochromatosis.
Diabetes & metabolism 2002 Feb 28 (1): 33-8. Van Lerberghe S, Hermans M P, Dahan K, Buysschaert |
|
Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy.
Diabetes care 2001 Jul 24 (7): 1187-91. Moczulski D K, Grzeszczak W, Gawlik |
|
HFE mutations in African-American women with non-insulin-dependent diabetes mellitus.
Ethnicity & disease 2001 11 (4): 578-84. Acton R T, Barton J C, Bell D S, Go R C, Roseman J |
|
Mutation H63D in the HFE gene confers risk for the development of type 2 diabetes mellitus but not for chronic complications.
Journal of diabetes and its complications 0 25 (1): 25-30. Colli Máikel L, Gross Jorge L, Canani Luis |
- Page last reviewed:Jul 30, 2019
- Page last updated:Nov 14, 2019
- Content source: